Olivier Bertrand The use of abciximab perfusion after stenting was questioned at the American Heart Association meeting in Dallas. The EASY study found bolus administration of glycoprotein 2B3A inhibi
Olivier Bertrand
The use of abciximab perfusion after stenting was questioned at the American Heart Association meeting in Dallas. The EASY study found bolus administration of glycoprotein 2B3A inhibition was sufficient and gives the possibility of sending patients home early.Olivier Bertrand, Hôpital Laval, Quebec.
[audio:https://www.audiomedica.com/podcasting/aha2005/Olivier_Bertrand.mp3]